PRESS RELEASE published on 09/22/2026 at 22:15, 1 month ago Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Nanobiotix publie les informations mensuelles sur les droits de vote et d'actions. La société de biotechnologie développe des thérapies innovantes en oncologie et autres domaines Innovation Droits De Vote Biotechnologie Oncologie NANOBIOTIX
PRESS RELEASE published on 09/22/2026 at 22:15, 1 month ago Voting Rights and Shares Capital of the Company Nanobiotix updates voting rights and shares capital, listed on Euronext Paris and Nasdaq. Company dedicated to innovative biotechnology solutions. Visit www.nanobiotix.com Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 09/21/2026 at 11:57, 1 month 1 day ago Goldman Sachs reaches thresholds in NANOBIOTIX Actions Goldman Sachs Threshold Crossing NANOBIOTIX Walk
BRIEF published on 09/21/2026 at 11:57, 1 month 1 day ago Franchissement de seuils par Goldman Sachs dans NANOBIOTIX Franchissement De Seuil Actions Marché Goldman Sachs NANOBIOTIX
PRESS RELEASE published on 09/21/2026 at 11:52, 1 month 1 day ago Franchissements de seuils Déclaration de franchissements de seuils par The Goldman Sachs Group, Inc. pour NANOBIOTIX sur Euronext Paris, avec acquisition et cession d'actions Euronext Paris Actions Franchissement De Seuils Goldman Sachs NANOBIOTIX
BRIEF published on 09/04/2026 at 14:56, 1 month 18 days ago NANOBIOTIX: Goldman Sachs reaches new thresholds Shares Goldman Sachs NANOBIOTIX Walk Threshold Crossings
BRIEF published on 09/04/2026 at 14:56, 1 month 18 days ago NANOBIOTIX : Franchissement de seuils par Goldman Sachs Actions Franchissement De Seuils Marché Goldman Sachs NANOBIOTIX
PRESS RELEASE published on 09/04/2026 at 14:51, 1 month 18 days ago Franchissement de seuils Déclaration de franchissement de seuils par The Goldman Sachs Group, Inc. concernant les actions de NANOBIOTIX Déclaration Actions Goldman Sachs Group Franchissement De Seuils NANOBIOTIX
BRIEF published on 07/30/2026 at 22:20, 2 months 23 days ago Nanobiotix: Monthly update on voting rights and shares Share Capital Voting Rights Biotechnology NANOBIOTIX Euronext Nasdaq
BRIEF published on 07/30/2026 at 22:20, 2 months 23 days ago Nanobiotix : Mise à jour mensuelle sur les droits de vote et actions Droits De Vote Capital Social Biotechnologie NANOBIOTIX Euronext Nasdaq
Published on 10/23/2026 at 02:20, 2 hours 21 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 5 hours 11 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 6 hours 11 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 12 hours 41 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 14 hours 11 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 01:55, 2 hours 46 minutes ago Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 6 hours 31 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 8 hours 41 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 8 hours 56 minutes ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 9 hours 56 minutes ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:00, 10 hours 41 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 10 hours 41 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 10 hours 41 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 10 hours 41 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 10 hours 41 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
